Indeed, treatment with angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARB) are proven to be protective for heart failure and prevent left ventricular stiffness in humans, most likely as a direct consequence of reduced angiotensin II levels (Wright et al., 2008). This evidence concerns the gene AGT and heart failure.